Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules
Fig 3
Functional and pathway enrichment analysis of differentially expressed genes.
(A) The functions and pathways differentially expressed genes (diabetic mice VS normal mice) involved in. (B) The functions and pathways differentially expressed genes (diabetic vascular lesions VS diabetic mice) involved in. (C) The functions and pathways differentially expressed genes in SHENQI compound group involved in. (D) The functions and pathways differentially expressed genes in rosiglitazone group involved in.